Antithrombotic Therapy for Venous Thromboembolic Disease
- 1 November 1998
- Vol. 114 (5), 561S-578S
- https://doi.org/10.1378/chest.114.5_supplement.561s
Abstract
No abstract availableThis publication has 76 references indexed in Scilit:
- Regional Right Ventricular Dysfunction Detected by Echocardiography in Acute Pulmonary EmbolismThe American Journal of Cardiology, 1996
- A multicentre comparison of once‐daily subcutaneous dalteparin (low molecular weight heparin) and continuous intravenous heparin in the treatment of deep vein thrombosisJournal of Internal Medicine, 1996
- Optimum duration of anticoagulation for deep-vein thrombosis and pulmonary embolismThe Lancet, 1992
- The Antithrombotic Activity and Pharmacokinetics of Enoxaparine, A Low Molecular Weight Heparin, In Humans Given Single Subcutaneous Doses of 20 to 80 mgThe Journal of Clinical Pharmacology, 1988
- Heparin and the In-Hospital Management of Deep Venous Thrombosis: Cost ConsiderationsMayo Clinic Proceedings, 1986
- Thromboembolism, Coumarin Necrosis, and Protein CMayo Clinic Proceedings, 1985
- Is warfarin sodium contraindicated in the lactating mother?The Journal of Pediatrics, 1983
- Heparin therapy: A randomized prospective studyAmerican Heart Journal, 1979
- Arterial thromboembolic complications with aortic ball valve prosthesesAmerican Heart Journal, 1978
- PROTHROMBIN-TIME AND THROMBOTEST IN INJURED PATIENTS ON PROPHYLACTIC ANTICOAGULANT THERAPYThe Lancet, 1964